blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2989084

EP2989084 - CRYSTAL MODIFICATIONS OF ELOBIXIBAT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.12.2017
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  23.12.2016
FormerGrant of patent is intended
Status updated on  07.12.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
ELOBIX AB
Arvid Wallgrens Backe 20
413 46 Göteborg / SE
[2016/09]
Inventor(s)01 / BOHLIN, Martin
Kalmgatan 23
121 45 Johanneshov / SE
02 / TJERNELD, Erica
Olympiavägen 90
122 40 Enskede / SE
03 / VESTERMARK, Andreas
Snickerigatan 14
126 26 Stockholm / SE
04 / YMÉN, Ingvar
Gundersbergsvägen 8
132 48 Saltsjö-boo / SE
 [2016/09]
Representative(s)Novitas Patent AB
P.O. Box 55557
102 04 Stockholm / SE
[2016/09]
Application number, filing date14719331.225.04.2014
[2016/09]
WO2014EP58432
Priority number, dateSE2013005051726.04.2013         Original published format: SE 1350517
[2016/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014174066
Date:30.10.2014
Language:EN
[2014/44]
Type: A1 Application with search report 
No.:EP2989084
Date:02.03.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 30.10.2014 takes the place of the publication of the European patent application.
[2016/09]
Type: B1 Patent specification 
No.:EP2989084
Date:25.01.2017
Language:EN
[2017/04]
Search report(s)International search report - published on:EP30.10.2014
ClassificationIPC:C07D281/10, A61K31/554, A61P1/16
[2016/09]
CPC:
C07D281/10 (EP,KR,RU,US); A61K31/554 (EP,KR,RU,US); A61P1/04 (EP);
A61P1/10 (EP); A61P1/12 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P17/02 (EP); A61P17/04 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/08 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P37/02 (EP); A61P43/00 (EP); A61P5/48 (EP);
A61P5/50 (EP); C07D281/02 (EP,US); C07B2200/13 (KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/09]
Extension statesBA06.11.2015
ME06.11.2015
TitleGerman:KRISTALLMODIFIKATIONEN VON ELOBIXIBAT[2016/09]
English:CRYSTAL MODIFICATIONS OF ELOBIXIBAT[2016/09]
French:MODIFICATIONS CRISTALLINES D'ÉLOBIXIBAT[2016/09]
Entry into regional phase06.11.2015National basic fee paid 
06.11.2015Designation fee(s) paid 
06.11.2015Examination fee paid 
Examination procedure06.11.2015Examination requested  [2016/09]
07.06.2016Amendment by applicant (claims and/or description)
29.09.2016Communication of intention to grant the patent
06.12.2016Fee for grant paid
06.12.2016Fee for publishing/printing paid
06.12.2016Receipt of the translation of the claim(s)
Opposition(s)26.10.2017No opposition filed within time limit [2018/01]
Fees paidRenewal fee
30.03.2016Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.04.2014
AL25.01.2017
CY25.01.2017
CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
MK25.01.2017
RO25.01.2017
RS25.01.2017
SI25.01.2017
SK25.01.2017
SM25.01.2017
BG25.04.2017
LU25.04.2017
MT25.04.2017
GR26.04.2017
IS25.05.2017
[2020/34]
Former [2019/52]HU25.04.2014
CY25.01.2017
CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
MK25.01.2017
RO25.01.2017
RS25.01.2017
SI25.01.2017
SK25.01.2017
SM25.01.2017
BG25.04.2017
LU25.04.2017
MT25.04.2017
GR26.04.2017
IS25.05.2017
Former [2019/48]HU25.04.2014
CY25.01.2017
CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
RO25.01.2017
RS25.01.2017
SI25.01.2017
SK25.01.2017
SM25.01.2017
BG25.04.2017
LU25.04.2017
MT25.04.2017
GR26.04.2017
IS25.05.2017
Former [2019/31]HU25.04.2014
CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
RO25.01.2017
RS25.01.2017
SI25.01.2017
SK25.01.2017
SM25.01.2017
BG25.04.2017
LU25.04.2017
MT25.04.2017
GR26.04.2017
IS25.05.2017
Former [2018/43]CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
RO25.01.2017
RS25.01.2017
SI25.01.2017
SK25.01.2017
SM25.01.2017
BG25.04.2017
LU25.04.2017
MT25.04.2017
GR26.04.2017
IS25.05.2017
Former [2018/14]CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
RO25.01.2017
RS25.01.2017
SI25.01.2017
SK25.01.2017
SM25.01.2017
BG25.04.2017
LU25.04.2017
GR26.04.2017
IS25.05.2017
Former [2018/06]CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
MC25.01.2017
RO25.01.2017
RS25.01.2017
SK25.01.2017
SM25.01.2017
BG25.04.2017
GR26.04.2017
IS25.05.2017
Former [2017/51]CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
RO25.01.2017
RS25.01.2017
SK25.01.2017
SM25.01.2017
BG25.04.2017
GR26.04.2017
IS25.05.2017
Former [2017/49]CZ25.01.2017
EE25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
RO25.01.2017
RS25.01.2017
SK25.01.2017
BG25.04.2017
GR26.04.2017
IS25.05.2017
Former [2017/48]CZ25.01.2017
HR25.01.2017
LT25.01.2017
LV25.01.2017
RS25.01.2017
BG25.04.2017
GR26.04.2017
IS25.05.2017
Former [2017/41]HR25.01.2017
LT25.01.2017
LV25.01.2017
RS25.01.2017
BG25.04.2017
GR26.04.2017
IS25.05.2017
Cited inInternational search[AD]WO0250051  (ASTRAZENECA AB [SE], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.